A Dose Escalation and Expansion Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RO7283420.
Clinical trial NCT04580121 · COMPLETED
Trial details
- NCT number
- NCT04580121
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-11-04
- Primary completion
- 2023-08-09
- Enrollment
- 59
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.